| The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020 SE Oliver MMWR. Morbidity and mortality weekly report 69, 2020 | 909* | 2020 |
| First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA I Ghinai, TD McPherson, JC Hunter, HL Kirking, D Christiansen, K Joshi, ... The Lancet 395 (10230), 1137-1144, 2020 | 723 | 2020 |
| Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021 JW Gargano MMWR. Morbidity and mortality weekly report 70, 2021 | 590 | 2021 |
| Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020 A Patel MMWR. Morbidity and mortality weekly report 69, 2020 | 516 | 2020 |
| Public health responses to COVID-19 outbreaks on cruise ships—worldwide, February–March 2020 LF Moriarty MMWR. Morbidity and mortality weekly report 69, 2020 | 483 | 2020 |
| The Advisory Committee on Immunization Practices’ updated interim recommendation for allocation of COVID-19 vaccine—United States, December 2020 K Dooling MMWR. Morbidity and mortality weekly report 69, 2021 | 446 | 2021 |
| Persons evaluated for 2019 novel coronavirus—United States, January 2020 KL Bajema MMWR. Morbidity and mortality weekly report 69, 2020 | 376 | 2020 |
| The Advisory Committee on Immunization Practices’ interim recommendation for allocating initial supplies of COVID-19 vaccine—United States, 2020 K Dooling MMWR. Morbidity and mortality weekly report 69, 2020 | 360 | 2020 |
| Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Nature medicine 26 (6), 861-868, 2020 | 345 | 2020 |
| Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged≥ 65 years—United States, January–March 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 328 | 2021 |
| Update: characteristics of a nationwide outbreak of e-cigarette, or vaping, product use–associated lung injury—United States, August 2019–January 2020 VP Krishnasamy MMWR. Morbidity and mortality weekly report 69, 2020 | 281 | 2020 |
| Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with … JR MacNeil MMWR. Morbidity and mortality weekly report 70, 2021 | 204 | 2021 |
| COVID-19 in correctional and detention facilities—United States, February–April 2020 M Wallace MMWR. Morbidity and mortality weekly report 69, 2020 | 195 | 2020 |
| The Advisory Committee on Immunization Practices’ ethical principles for allocating initial supplies of COVID-19 vaccine—United States, 2020 N McClung MMWR. Morbidity and mortality weekly report 69, 2020 | 157 | 2020 |
| The Advisory Committee on Immunization Practices’ interim recommendations for additional primary and booster doses of COVID-19 vaccines—United States, 2021 S Mbaeyi MMWR. Morbidity and mortality weekly report 70, 2021 | 150 | 2021 |
| ’interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12–15 years—United States, May 2021 M Wallace, KR Woodworth, JW Gargano, ... MMWR Morb Mortal Wkly Rep 70 (20), 749-752, 2021 | 141 | 2021 |
| Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022 HG Rosenblum MMWR. Morbidity and mortality weekly report 71, 2022 | 113 | 2022 |
| First 12 patients with coronavirus disease 2019 (COVID-19) in the United States COVID-19 Investigation Team, SA Kujawski, KK Wong, JP Collins, ... MedRxiv, 2020.03. 09.20032896, 2020 | 111 | 2020 |
| The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12–15 years—United States, May 2021 M Wallace MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 110 | 2021 |
| Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices—United States, December 2021 SE Oliver MMWR. Morbidity and mortality weekly report 71, 2022 | 93 | 2022 |
